Inactive Instrument
BSF Enterprise Plc Stock OTC Markets
Stocks
BSFA.F
GB00BHNBDQ51
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.46M 1.96M 1.71M 1.58M 2.75M 188M 2.8M 18.85M 7.39M 92.02M 7.35M 7.19M 317M | P/E 2024 |
-2.47x | P/E 2025 | -3.56x |
|---|---|---|---|---|---|
| Enterprise Value | 1.31M 1.76M 1.54M 1.42M 2.47M 169M 2.51M 16.92M 6.64M 82.62M 6.6M 6.45M 284M | EV / Sales 2024 |
61,809,222x | EV / Sales 2025 | 76,138,323x |
| Free-Float |
80.4% | Yield 2024 * |
-
| Yield 2025 | - |
| 02-06 | BSF : Proxy Form | PU |
| 02-06 | BSF : Notice of AGM | PU |
| 06/03/25 | BSF : Publication of Prospectus | PU |
| 06/03/25 | BSF : Prospectus | PU |
| 07/02/25 | BSF : Proxy Form | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Che Connon
CEO | Chief Executive Officer | 54 | - |
Graham Duncan
DFI | Director of Finance/CFO | 63 | 06/06/2022 |
Ricardo Gouveia
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Geoffrey Baker
CHM | Chairman | 70 | 05/12/2025 |
Kian Jing Ow
BRD | Director/Board Member | 60 | 05/08/2021 |
Che Connon
BRD | Director/Board Member | 54 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.23M | |
| -0.65% | -2.40% | +15.67% | -8.15% | 67.46B | |
| -1.32% | -8.39% | +34.74% | +193.12% | 51.13B | |
| -2.29% | +36.80% | +36.80% | +36.80% | 43.4B | |
| +1.34% | -1.02% | -48.96% | -53.51% | 40.32B | |
| -7.97% | -5.97% | +45.30% | -30.66% | 30.86B | |
| +0.27% | -15.39% | +105.32% | -44.38% | 26.59B | |
| +0.34% | -2.91% | +63.78% | +85.57% | 22.82B | |
| +1.07% | -0.50% | +11.79% | +175.38% | 19.79B | |
| -1.56% | -5.38% | +53.69% | +123.21% | 16.47B | |
| Average | -1.08% | -3.41% | +35.35% | +53.04% | 35.43B | |
| Weighted average by Cap. | -1.25% | -2.79% | +28.94% | +44.20% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.06 0.08 0.07 0.06 0.11 7.44 0.11 0.75 0.29 3.64 0.29 0.28 12.55 | 0.05 0.07 0.06 0.06 0.1 6.8 0.1 0.68 0.27 3.33 0.27 0.26 11.47 |
| Net income | -1.67M -2.24M -1.96M -1.81M -3.15M -215M -3.21M -21.59M -8.47M -105M -8.42M -8.23M -363M | -1.11M -1.49M -1.3M -1.21M -2.1M -143M -2.13M -14.37M -5.64M -70.17M -5.6M -5.48M -242M |
| Net Debt | -560K -750K -655K -606K -1.05M -72.02M -1.07M -7.22M -2.83M -35.26M -2.82M -2.75M -121M | -149K -200K -174K -161K -281K -19.18M -286K -1.92M -755K -9.39M -750K -733K -32.34M |
Employees
14
Sector
Pharmaceuticals
Choose MarketScreener 
